for Target Diagnoses of Low-Grade Squamous Intraepithelial Lesion (LSIL), High-Grade Squamous Intraepithelial Lesion (HSIL), and Squamous Cell Carcinoma (SCC) by Year Target Diagnosis 2006 2007 LSIL concordance rate
, 967 (79.
In studies of quality measurement applications that involve describing or comparing facilities, it is important to know and account for the varying facility-level concordance rates
of mirrored characters in percent A B C D E F G 99 94 96 96 94 86 95 H I J K L M N 100 100 93 95 92 100 93 O P Q R S T U 99 97 91 93 91 100 96 V W X Y Z 99 96 99 93 81
The concordance rate
for identical twins (52 percent) was much higher than the concordance rate
for the fraternal twins (22 percent).
Perhaps those with fewer planned visits have a higher concordance rate
because of the possibility that the task of the intake care manager is simplified for those needing fewer services, and the concordance rate
for those with a larger number of initial planned visits might be lower, because the task of the intake care manager is more difficult.
The low concordance rate
among monozygotic and dizygotic twins, as well as the similar prevalence in twins and in the general population, "supports the hypothesis that nonhereditary factors are important in the cause of Parkinson's disease," the researchers concluded.
The degree of concordance was assessed by calculating, for each needle group, a kappa statistic, overall concordance rate
and the risk to undergrade a biopsy GS=6.
For each tumor sample, the per-specimen concordance rate
was calculated as the proportion of raters who provided a classification that was the same as that of the reference evaluation.
Among the female dizygotic twins of 76 boys with ASD, the probandwise concordance rate
The concordance rate
was calculated by dividing the number of matched SNPs by the number of SNPs compared.
The [kappa] statistic is very sensitive to marginal values; if the marginal values are not well balanced, the value will be low even if the concordance rate
is high .
The primary endpoint for both the NEO3-05 and NEO3-09 trials was the comparison (the Concordance Rate
, or the rate of agreement) of Lymphoseek versus vital blue dye, a long-standing, FDA-approved, on-label agent for lymphatic mapping and appropriate requisite "Truth Standard" comparator for registration purposes.